MADRID, 18 Mar. (EUROPA PRESS) –
Grifols shares soared more than 3% this Monday on the stock market around 9:15 a.m., in a context marked by the movements of bearish funds and by the wait for the analysis of the information required from the blood products company by the National Commission. of the Stock Market (CNMV) after the crisis unleashed by the report published by Gotham City Research.
Thus, Grifols began to lead the rise of the Ibex 35 with a rise of 3.4%, until exchanging its shares at a price of 7.786 euros, after having started the session with a rise of 0.27%, with its shares at 7,550 euros.
So far this year, the Catalan company has recorded an accumulated depreciation of 50.23%, while the market capitalization has been slightly above 4,620 million euros.
The president of the CNMV, Rodrigo Buenaventura, already announced more than a week ago that the analysis of the information required from Grifols following the Gotham City Research report “is very advanced.”
He also explained that the supervisor’s “number one” priority is to clarify the situation in relation to the financial information published by Grifols and the bearish fund report that “calls it into question.”
